MedImmune Ventures is a venture capital firm that is invested in healthcare technology companies. The firm was founded in 2002 in Gaithersburg, Maryland, United States, and is a sub-organization of MedImmune.
The fund is a wholly owned venture fund within the AstraZeneca/MedImmune group of companies. The firm looks to discover, develop, commercialize, and finance new biotechnology products in order to transform them from products to companies. Public and private companies are attractive to the firm.